216 related articles for article (PubMed ID: 16789014)
21. Response to HAART in French patients with resistant HIV-1 treated at primary infection: ANRS Resistance Network.
Chaix ML; Desquilbet L; Descamps D; Costagliola D; Deveau C; Galimand J; Goujard C; Signori-Schmuck A; Schneider V; Tamalet C; Pellegrin I; Wirden M; Masquelier B; Brun-Vezinet F; Rouzioux C; Meyer L; ;
Antivir Ther; 2007; 12(8):1305-10. PubMed ID: 18240870
[TBL] [Abstract][Full Text] [Related]
22. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART.
Saracino A; Gianotti N; Marangi M; Cibelli DC; Galli A; Punzi G; Monno L; Lazzarin A; Angarano G;
J Med Virol; 2008 Oct; 80(10):1695-706. PubMed ID: 18712823
[TBL] [Abstract][Full Text] [Related]
23. Proof of principle: an HIV p24 microsphere immunoassay with potential application to HIV clinical diagnosis.
Ondoa P; Vereecken C; Asahchop EL; Litzroth A; Diallo A; Fransen K; Dieye T; Ryder R; Mboup S; Kestens L
Cytometry B Clin Cytom; 2009 May; 76(3):231-6. PubMed ID: 19012321
[TBL] [Abstract][Full Text] [Related]
24. The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.
Maggiolo F; Ripamonti D; Torti C; Arici C; Antinori A; Quiros-Roldan E; Minoli L; Sighinolfi L; Nasta P; Suter F;
Antivir Ther; 2006; 11(7):923-9. PubMed ID: 17302255
[TBL] [Abstract][Full Text] [Related]
25. Few modifications of the Cobas Amplicor HIV Monitor 1.5 test allow reliable quantitation of HIV-1 proviral load in peripheral blood mononuclear cells.
Lillo FB; Grasso MA; Lodini S; Bellotti MG; Colucci G
J Virol Methods; 2004 Sep; 120(2):201-5. PubMed ID: 15288963
[TBL] [Abstract][Full Text] [Related]
26. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
27. Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures.
Tschochner M; Schwingel E; Thein C; Wittmann S; Paatz C; Walter H
J Virol Methods; 2007 Apr; 141(1):87-96. PubMed ID: 17196267
[TBL] [Abstract][Full Text] [Related]
28. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
29. Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load.
Stelzl E; Troppan KT; Winkler M; Korn K; Kessler HH
J Virol Methods; 2010 Sep; 168(1-2):152-4. PubMed ID: 20471425
[TBL] [Abstract][Full Text] [Related]
30. Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.
Le Moing V; Thiébaut R; Chêne G; Sobel A; Massip P; Collin F; Meyohas M; Al Kaïed F; Leport C; Raffi F;
HIV Med; 2007 Apr; 8(3):156-63. PubMed ID: 17461859
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.
Schüpbach J; Böni J; Flepp M; Tomasik Z; Joller H; Opravil M
J Med Virol; 2001 Oct; 65(2):225-32. PubMed ID: 11536227
[TBL] [Abstract][Full Text] [Related]
32. A simple competitive RT-PCR assay for quantitation of HIV-1 subtype B and non-B RNA in plasma.
Hamatake M; Nishizawa M; Yamamoto N; Kato S; Sugiura W
J Virol Methods; 2007 Jun; 142(1-2):113-7. PubMed ID: 17367872
[TBL] [Abstract][Full Text] [Related]
33. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
34. ARCHITECT® HIV Ag/Ab Combo assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates.
Brennan CA; Yamaguchi J; Vallari A; Swanson P; Hackett JR
J Clin Virol; 2013 Jun; 57(2):169-72. PubMed ID: 23485348
[TBL] [Abstract][Full Text] [Related]
35. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
[TBL] [Abstract][Full Text] [Related]
36. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
Geretti AM; Smith C; Haberl A; Garcia-Diaz A; Nebbia G; Johnson M; Phillips A; Staszewski S
Antivir Ther; 2008; 13(7):927-36. PubMed ID: 19043927
[TBL] [Abstract][Full Text] [Related]
37. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
[TBL] [Abstract][Full Text] [Related]
38. [Genotypic resistance in HIV-1-infected patients with persistent low-level viremia].
Parra-Ruiz J; Alvarez M; Chueca N; Peña A; Pasquau J; López-Ruz MA; Maroto Mdel C; Hernández-Quero J; García F
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):75-80. PubMed ID: 19254638
[TBL] [Abstract][Full Text] [Related]
39. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
[TBL] [Abstract][Full Text] [Related]
40. LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).
Avettand-Fènoël V; Chaix ML; Blanche S; Burgard M; Floch C; Toure K; Allemon MC; Warszawski J; Rouzioux C;
J Med Virol; 2009 Feb; 81(2):217-23. PubMed ID: 19107966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
